|
Highlight |
• May 4th, 2009
Fovea Reports Positive Results with Prednisporin™ in Persistent Allergic Conjunctivitis
 read more
|
• February 10th, 2009
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
read more |
| |
|
Agenda
- “Combination Products: Improving
Product Life Cycles, Extending
Lines,
and Creating Novel Therapeutics”
June 1-2, 2009 in Cambridge (USA)
- “Peptide Receptors and Kinin 2009”; June 26-30, 2009 in Montreal (Canada)
- “Biopharmaceutical Conference in Europe” June 17-19, 2009 in Monte-Carlo
|
|
